Celia Vélez
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 8
- Cancer therapeutics and mechanisms 6
- Oncology 18
- Peptidase Inhibition and Analysis 5
- Co-authors
- Consolación Melguizo (36 shared papers)José Prados (32 shared papers)Antonia Aránega (35 shared papers)Pablo Álvarez (7 shared papers)Juan Antonio Marchal (18 shared papers)Raúl Ortíz (9 shared papers)Houría Boulaiz (14 shared papers)Esmeralda Carrillo (12 shared papers)
- Journals
- Cells Tissues Organs (5 papers)American Journal of Veterinary Research (2 papers)Journal of Cardiovascular Pharmacology (2 papers)International Journal of Molecular Sciences (2 papers)Life Sciences (2 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Celia Vélez
54 papers receiving 698 citations
Peers
Comparison fields: 5 of 99
- Biomaterials 128
- Oncology 181
- Molecular Medicine 26
- Molecular Biology 321
- Cancer Research 55
Countries citing papers authored by Celia Vélez
This map shows the geographic impact of Celia Vélez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia Vélez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia Vélez more than expected).
Fields of papers citing papers by Celia Vélez
This network shows the impact of papers produced by Celia Vélez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia Vélez. The network helps show where Celia Vélez may publish in the future.
Co-authors
The 25 scholars most cited alongside Celia Vélez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 111 | |
| 2 | 2012 | 92 | |
| 3 | 2013 | 38 | |
| 4 | 2015 | 33 | |
| 5 | 1976 | 30 | |
| 6 | 2016 | 28 | |
| 7 | 1992 | 27 | |
| 8 | 2003 | 24 | |
| 9 | 2009 | 21 | |
| 10 | 1995 | 19 | |
| 11 | 1997 | 18 | |
| 12 | 2019 | 15 | |
| 13 | 2015 | 14 | |
| 14 | 1998 | 14 | |
| 15 | 2010 | 12 | |
| 16 | 2007 | 12 | |
| 17 | Actinomycin D causes multidrug resistance and differentiation in a human rhabdomyosarcoma cell line. | 1994 | 12 |
| 18 | 1999 | 11 | |
| 19 | 2012 | 10 | |
| 20 | 2002 | 10 |
About Celia Vélez
Celia Vélez is a scholar working on Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Cell Biology, having authored 55 papers that have together received 717 indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (9 papers), RNA Interference and Gene Delivery (8 papers), Cancer therapeutics and mechanisms (6 papers), Sarcoma Diagnosis and Treatment (6 papers), Cardiovascular Effects of Exercise (5 papers), Peptidase Inhibition and Analysis (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Biomaterials (128 citations), Oncology (181 citations), Molecular Medicine (26 citations), Molecular Biology (321 citations) and Cancer Research (55 citations). Celia Vélez has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Consolación Melguizo, José Prados, Antonia Aránega, Pablo Álvarez, Juan Antonio Marchal, Raúl Ortíz, Houría Boulaiz, Esmeralda Carrillo, Fernando Rodríguez‐Serrano and José L. Arias. Their work appears in journals such as Cells Tissues Organs, American Journal of Veterinary Research, Journal of Cardiovascular Pharmacology, International Journal of Molecular Sciences and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.